Gene assembling: a new approach in molecular diagnosis of hereditary breast cancer
Authors
Abstract:
Abstract Background: Many disease susceptibility genes are large and consist of many exons in which point mutations are scattered throughout. Scanning each exon individually represents a tedious task which can be time consuming and expensive. There has been increasing demand for rapid and accurate methods for full scanning of unknown point mutations in large multi-exon genes. Gene Assembling is a new method for creating chimeric DNA molecules using a modified PCR reaction that allows maximizing the length of sequence that can be scanned by sensitive downstream technique. Methods: In the present study assembling of exons 2, 20, 23 and 24 of the BRCA1 gene and their subsequent analysis by direct sequencing is demonstrated. The BRCA1 exons 2 and 20 are hot spot regions that are known to harbor particularly deleterious mutations. In order to avoid missing any mutation in these two exons, the four exons previously mentioned were assembled in the following order of preferences: 23, 20, 2 and 24. However, the order of fragments can be predetermined by primer design. Results: The order and sequence of the component exons in the gene-assembled products were characterized by direct sequencing as predicted. Gene-assembled products from three previously ascertained heterozygotes for BRCA1 mutations were directly sequenced and gave the same sequence patterns. Conclusion: This experience suggests that Gene Assembling technique could be applied as a highly sensitive and cost-effective method in identifying mutation in complex genes such as BRCA and ColA1/2 helping clinical molecular diagnostic laboratories, to fulfill the demand for scanning complex genetic diseases at a lower cost.
similar resources
gene assembling: a new approach in molecular diagnosis of hereditary breast cancer
abstract background: many disease susceptibility genes are large and consist of many exons in which point mutations are scattered throughout. scanning each exon individually represents a tedious task which can be time consuming and expensive. there has been increasing demand for rapid and accurate methods for full scanning of unknown point mutations in large multi-exon genes. gene assembling is...
full textthe study of aaag repeat polymorphism in promoter of errg gene and its association with the risk of breast cancer in isfahan region
چکیده: سرطان پستان دومین عامل مرگ مرتبط با سرطان در خانم ها است. از آنجا که سرطان پستان یک تومور وابسته به هورمون است، می تواند توسط وضعیت هورمون های استروئیدی شامل استروژن و پروژسترون تنظیم شود. استروژن نقش مهمی در توسعه و پیشرفت سرطان پستان ایفا می کند و تاثیر خود را روی بیان ژن های هدف از طریق گیرنده های استروژن اعمال می کند. اما گروه دیگری از گیرنده های هسته ای به نام گیرنده های مرتبط به ا...
15 صفحه اولMolecular imaging approaches in the diagnosis of breast cancer: A systematic review and meta-analysis
Introduction:The accuracy of positron emission tomography with computed tomography (PET/CT), positron emission mammography (PEM), and breast specific-gamma imaging (BSGI) in diagnosing breast cancer has never been systematically assessed, the present systematic review was aimed to address this issue. Methods:PubMed, Scopus and EMBASE were searched for st...
full textEvaluation of Nucleostemin Gene Expression as a New Molecular Marker in Breast Tumors
Background & Aims: Nucleostemin is one of the stem cell enriched proteins which encodes a novel nucleolar GTP-binding protein found at high levels in the adult and embryonic stem (ES) cells but not in terminally differentiated cells. It is also expressed in tumor cell lines as well as in the several types of human cancers. Due to the increasing rate of breast cancer in recent years, in the pres...
full textThe molecular pathology of hereditary breast cancer.
Hereditary breast cancer arising in carriers of mutations in the BRCA1 and BRCA2 genes differs from sporadic breast cancer and from non-BRCA1/2 familial breast carcinomas. Most BRCA1 carcinomas have the basal-like phenotype and are high-grade, highly proliferating, estrogen receptor-negative and HER2-negative breast carcinomas, characterized by the expression of basal markers such as basal kera...
full textMy Resources
Journal title
volume 21 issue 1
pages 29- 37
publication date 2007-05
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023